ALLERGY THERAPEUTICS PLC

Remuneration Information • May 15, 2013

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 7701E

Allergy Therapeutics PLC

15 May 2013

15 May 2013

Allergy Therapeutics plc

("Allergy Therapeutics" or "the Company")

Grant of Options

Allergy Therapeutics plc (AIM: AGY) announces that, pursuant to the new Allergy Therapeutics plc Long Term Share Incentive Plan ('LTIP') on 15 May 2013 provisional shares of 0.1 pence each in the share capital of the Company were awarded to the following Board Directors, Mr Manuel Llobet (Chief Executive Officer) and Mr Ian Postlethwaite (Finance Director) at nil cost, as follows:

Director	Number of provisional shares awarded	Date of distribution	Total provisional shares held under LTIPs
Manuel Llobet	905,000	15 May 2013	3,065,000
Ian Postlethwaite	452,500	15 May 2013	1,532,500

The issuance and distribution of ordinary shares of 0.1 pence each under the LTIP is conditional on the Company's performance over the course of three years.  The new Long Term Incentive Plan was adopted by the Board on 20 March 2013.

-Ends-

For further information:

Allergy Therapeutics	+44 (0) 1903 845 820
Manuel Llobet, Chief Executive Officer
Nomura Code Securities	+44 (0) 207 776 1200
Juliet Thompson/ Clare Terlouw

This information is provided by RNS

The company news service from the London Stock Exchange

END

MSCGCGDUCBBBGXU